LivaNova PLC
LIVN
Kedudukan dalam Saham
#3840
LivaNova PLC is a global medical technology company dedicated to developing,... LivaNova PLC is a global medical technology company dedicated to developing, manufacturing, and marketing a variety of therapeutic solutions. The company operates through three key segments. Its Cardiopulmonary division provides essential products for heart-lung procedures, such as oxygenators, heart-lung machines, and various perfusion systems. The Neuromodulation segment is known for its VNS Therapy System, an implantable device that delivers vagus nerve stimulation to treat drug-resistant epilepsy, difficult-to-treat depression, and obstructive sleep apnea. This segment is also advancing the VITARIA System, which employs VNS for heart failure, through clinical development. The Advanced Circulatory Support segment offers temporary life support solutions, including both cardiopulmonary and respiratory support technologies. LivaNova serves a wide range of medical professionals, including perfusionists, neurologists, neurosurgeons, and other physicians, as well as hospitals and healthcare providers. The company's products are distributed globally through both its direct sales force and independent distributors. Additionally, LivaNova has a research collaboration with Verily aimed at discovering clinical biomarkers for depression. Founded in 1987, the company is headquartered in London, United Kingdom.
Harga Saham
$78.37
Disegerakkan terakhir: 2026-10-19
Modal Pasaran
$4.31B
Perubahan (1 hari)
1.02%
Perubahan (1 tahun)
44.86%
Negara
GB
Perdagangan LivaNova PLC (LIVN)
Kategori
Healthcare
Margin Operasi untuk LivaNova PLC (LIVN)
Margin Operasi pada October 2026 TTM: 13.48%
Menurut laporan kewangan dan harga saham terkini LivaNova PLC, margin operasi semasa (TTM) ialah 13.48%. Pada akhir 2023, margin operasi syarikat ialah -5.94%.
Sejarah Margin Operasi untuk LivaNova PLC dari 2000 hingga 2026
Margin Operasi pada akhir setiap tahun
| Tahun | Margin Operasi | Ubah |
|---|---|---|
| 2026 (TTM) | 13.48% | 30.87% |
| 2024 | 10.30% | -273.40% |
| 2023 | -5.94% | -215.12% |
| 2022 | 5.16% | -5,833.33% |
| 2021 | -0.09% | -98.03% |
| 2020 | -4.58% | -203.39% |
| 2019 | 4.43% | -119.77% |
| 2018 | -22.41% | -337.14% |
| 2017 | 9.45% | -516.30% |
| 2016 | -2.27% | -107.46% |
| 2015 | 30.41% | -1.30% |
| 2013 | 30.81% | 10.47% |
| 2012 | 27.89% | 7.98% |
| 2011 | 25.83% | 17.57% |
| 2010 | 21.97% | 66.19% |
| 2009 | 13.22% | -294.70% |
| 2008 | -6.79% | -82.05% |
| 2007 | -37.82% | -21.18% |
| 2006 | -47.98% | 284.46% |
| 2005 | -12.48% | -306.28% |
| 2004 | 6.05% | 35.04% |
| 2003 | 4.48% | -111.54% |
| 2002 | -38.81% | 0.00% |
| 2001 | 0.00% | -100.00% |
| 2000 | -10.97% | 0.00% |
Margin Operasi untuk syarikat serupa atau pesaing
| Syarikat | Margin Operasi | Perbezaan Margin Operasi | Negara |
|---|---|---|---|
| 17.03% | -98.74% |
US
|
|
| 17.86% | -98.68% |
IE
|
|
| 22.03% | -98.37% |
US
|
|
| 21.46% | -98.41% |
US
|
|
| 0.00% | - |
DE
|
Apakah Margin Operasi sesebuah syarikat?
Margin Operasi ialah penunjuk utama untuk menilai keuntungan sesebuah syarikat. Margin Operasi yang lebih tinggi lazimnya lebih baik kerana menunjukkan bahawa syarikat mampu menjual produk atau perkhidmatannya dengan harga yang jauh lebih tinggi daripada kos pengeluarannya. Ia dikira dengan membahagikan keuntungan syarikat dengan hasilnya.